Literature DB >> 18617780

Heparanase-2, syndecan-1, and extracellular matrix remodeling in colorectal carcinoma.

Thais Peretti1, Jaques Waisberg, Ana Maria A A Mader, Leandro L de Matos, Ricardo B da Costa, Gleice Margarete de S Conceição, Antônio Carlos Lopes, Helena B Nader, Maria Aparecida S Pinhal.   

Abstract

AIM: To propose a quantitative method to detect heparanase-2 (HPA2) and syndecan-1 (Syn-1) using immunohistochemistry in colorectal (colon and rectal) carcinomas compared with nonneoplastic tissues and evaluate the possible role of these molecules in tumor development and extracellular remodeling.
METHODS: Cytoplasmic staining of HPA2 and Syn-1 was obtained by standard immunohistochemical reactions in 50 colorectal carcinoma and 20 nonneoplastic large bowels tissues. An image system was used to quantify the immunoexpression by digital computer-assisted method (Matos et al. 2006). The cutoff point for the immunohistochemistry variable was defined by sensibility and specificity curves. Statistical analysis was performed using SPSS version 13.0.
RESULTS: HPA2 was over-expressed in colorectal cancer (131.1+/-24.9 o.u./microm) when compared with nonneoplastic tissues (27.9+/-12.2 o.u./microm) (P<0.0001). However, an opposite correlation was observed between Syn-1 and tumor presence, where colorectal tissues expressed lower Syn-1 proteoglycan compared with nonneoplastic tissues, respectively (39.2+/-17.8 o.u./microm) and (102.2+/-25.2 o.u./microm) (P<0.0001).
CONCLUSION: A methodology with high sensitivity and specificity is proposed with a cutoff value for HPA2 and Syn-1 in the immunohistochemistry assay to define the presence of tumor. It was demonstrated for the first time in the literature that HPA2 is over-expressed in colorectal carcinoma tissues compared with nonneoplastic tissues. HPA2 over-expression could be possibly related to Syn-1 shedding despite the fact that HPA2 does not present enzymatic activity as HPA1.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18617780     DOI: 10.1097/MEG.0b013e3282fc2649

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  17 in total

1.  Heparanase 2 interacts with heparan sulfate with high affinity and inhibits heparanase activity.

Authors:  Flonia Levy-Adam; Sari Feld; Victoria Cohen-Kaplan; Anna Shteingauz; Miriam Gross; Gil Arvatz; Inna Naroditsky; Neta Ilan; Ilana Doweck; Israel Vlodavsky
Journal:  J Biol Chem       Date:  2010-06-24       Impact factor: 5.157

Review 2.  Urofacial syndrome: a genetic and congenital disease of aberrant urinary bladder innervation.

Authors:  Adrian S Woolf; Helen M Stuart; Neil A Roberts; Edward A McKenzie; Emma N Hilton; William G Newman
Journal:  Pediatr Nephrol       Date:  2013-07-09       Impact factor: 3.714

3.  Heparin regulates colon cancer cell growth through p38 mitogen-activated protein kinase signalling.

Authors:  G Chatzinikolaou; D Nikitovic; A Berdiaki; A Zafiropoulos; P Katonis; N K Karamanos; G N Tzanakakis
Journal:  Cell Prolif       Date:  2009-10-21       Impact factor: 6.831

Review 4.  Common cancer in a wild animal: the California sea lion (Zalophus californianus) as an emerging model for carcinogenesis.

Authors:  Helen M Browning; Frances M D Gulland; John A Hammond; Kathleen M Colegrove; Ailsa J Hall
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-19       Impact factor: 6.237

5.  An immunohistochemical study of colon adenomas and carcinomas: E-cadherin, Syndecan-1, Ets-1.

Authors:  Zsuzsanna Pap; Zoltán Pávai; Lóránd Dénes; Ilona Kovalszky; János Jung
Journal:  Pathol Oncol Res       Date:  2009-03-01       Impact factor: 3.201

6.  Sdc1 negatively modulates carcinoma cell motility and invasion.

Authors:  Tohru Ishikawa; Randall H Kramer
Journal:  Exp Cell Res       Date:  2009-12-28       Impact factor: 3.905

7.  Heparanase isoform expression and extracellular matrix remodeling in intervertebral disc degenerative disease.

Authors:  Luciano Miller Reis Rodrigues; Thérèse Rachell Theodoro; Leandro Luongo Matos; Ana Maria Mader; Carlo Milani; Maria Aparecida da Silva Pinhal
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

8.  Evidence for a genetic basis of urogenital carcinoma in the wild California sea lion.

Authors:  Helen M Browning; Karina Acevedo-Whitehouse; Frances M D Gulland; Ailsa J Hall; Jeanie Finlayson; Mark P Dagleish; Karen J Billington; Kathleen Colegrove; John A Hammond
Journal:  Proc Biol Sci       Date:  2014-12-07       Impact factor: 5.349

9.  Prognostic significance of RSPO1, WNT1, P16, WT1, and SDC1 expressions in invasive ductal carcinoma of the breast.

Authors:  Eun Ji Choi; Jeong A Yun; Eun Kyoung Jeon; Hye Sung Won; Yoon Ho Ko; Su Young Kim
Journal:  World J Surg Oncol       Date:  2013-12-27       Impact factor: 2.754

10.  Immunohistochemical expression of heparanase isoforms and syndecan-1 proteins in colorectal adenomas.

Authors:  J Waisberg; T R Theodoro; L L Matos; F B Orlandi; R L Serrano; G T Saba; M A S Pinhal
Journal:  Eur J Histochem       Date:  2016-02-17       Impact factor: 3.188

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.